These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31926078)

  • 1. Machine learning as new promising technique for selection of significant features in obese women with type 2 diabetes.
    Lotfi H; Pirmoradi S; Mahmoudi R; Teshnehlab M; Sheervalilou R; Fekri Aval S; Zarghami N
    Horm Mol Biol Clin Investig; 2020 Jan; 41(1):. PubMed ID: 31926078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
    Li L; Yang G; Li Q; Tang Y; Yang M; Yang H; Li K
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):544-8. PubMed ID: 17177135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism rs9939609 of Fat Mass and Obesity-associated Gene Correlation with Leptin Level of Obese Women Suffered from Type 2 Diabetes.
    Moghanloo MN; Mohammadzadeh NA; Lotfi H; Mahmoudi R; Abbasi M; Alipour FG; Shool F; Porfaraj S; Zarghami N
    Curr Diabetes Rev; 2018; 14(6):559-564. PubMed ID: 28914195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compare the effects of different visfatin concentration on cardiovascular risk factors, adiponectin and insulin resistance in patients with T2DM.
    Mohammadi S; Hosseinzadeh-Attar MJ; Hosseinnezhad A; Hosseini SH; Eshraghian MR; Nezhad MK; Rahmani M; Karimi M
    Diabetes Metab Syndr; 2011; 5(2):71-5. PubMed ID: 22813406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
    Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
    Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.
    Silha JV; Krsek M; Skrha JV; Sucharda P; Nyomba BL; Murphy LJ
    Eur J Endocrinol; 2003 Oct; 149(4):331-5. PubMed ID: 14514348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals.
    Mabrouk R; Ghareeb H; Shehab A; Omar K; El-Kabarity RH; Soliman DA; Mohamed NA
    Egypt J Immunol; 2013; 20(1):1-11. PubMed ID: 23888552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.
    Mir MM; Mir R; Alghamdi MAA; Wani JI; Sabah ZU; Jeelani M; Marakala V; Sohail SK; O'haj M; Alharthi MH; Alamri MMS
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
    Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
    Mackawy AM
    Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
    Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
    Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
    Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY.
    Zaidi SI; Shirwany TA
    J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin Serum Levels in Obese Type 2 Diabetic Patients: Relation to Proinflammatory Cytokines and Insulin Resistance.
    Hetta HF; Ez-Eldeen ME; Mohamed GA; Gaber MA; ElBadre HM; Ahmed EA; Abdellatief RB; Abd-ElBaky RM; Elkady A; Nafee AM; Zahran AM; Ahmad M
    Egypt J Immunol; 2018 Jun; 25(2):141-151. PubMed ID: 30600957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.